メタ情報
| meta description平均長 | 0 |
|---|
| OGPありページ数 | 0 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 19 |
|---|
| ページあたり内部リンク平均 | 22.73 |
|---|
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| after | 1 |
| PSA | 0.909091 |
| tumor | 0.818182 |
| prostate | 0.805389 |
| Journal | 0.738877 |
| brachytherapy | 0.728685 |
| EBRT | 0.636364 |
| ncbi | 0.545455 |
| nlm | 0.545455 |
| nih | 0.545455 |
| gov | 0.545455 |
| was | 0.545455 |
| invasion | 0.545455 |
| ADT | 0.545455 |
| treatment | 0.545455 |
| bladder | 0.545455 |
| case | 0.517044 |
| サポート | 0.517044 |
| contemporary | 0.492585 |
| dose | 0.460222 |
| shows | 0.454545 |
| observed | 0.454545 |
| completion | 0.454545 |
| years | 0.454545 |
| seminal | 0.452413 |
| ブラキ | 0.443326 |
| BED | 0.42187 |
| https | 0.388596 |
| T3b | 0.387783 |
| Prostate | 0.387783 |
| vesicle | 0.387783 |
| Ten | 0.387783 |
| step | 0.387783 |
| method | 0.363636 |
| resonance | 0.363636 |
| cessation | 0.363636 |
| nodular | 0.363636 |
| into | 0.363636 |
| radiotherapy | 0.345167 |
| cancer | 0.344809 |
| low | 0.344809 |
| 2ng | 0.323152 |
| T3bN1 | 0.323152 |
| rate | 0.295551 |
| combination | 0.295551 |
| external | 0.295551 |
| beam | 0.295551 |
| pubmed | 0.272727 |
| pmc | 0.272727 |
| articles | 0.272727 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| サポート | ブラキ | 3.003802 | 26 |
| Journal | contemporary | 2.896075 | 37 |
| ncbi | nlm | 2.887876 | 24 |
| nih | nlm | 2.887876 | 24 |
| gov | nih | 2.887876 | 24 |
| beam | external | 2.887876 | 24 |
| seminal | vesicle | 2.773546 | 24 |
| Ten | step | 2.773546 | 24 |
| biologically | effective | 2.744073 | 20 |
| brachytherapy | contemporary | 2.659105 | 37 |
| EBRT | completion | 2.617611 | 21 |
| beam | radiotherapy | 2.587153 | 24 |
| adenocarcinoma | ductal | 2.566764 | 16 |
| high | risk | 2.517554 | 20 |
| ncbi | nih | 2.498588 | 20 |
| gov | nlm | 2.498588 | 20 |
| combination | external | 2.498588 | 20 |
| Method | Step | 2.486567 | 13 |
| dose | rate | 2.373786 | 24 |
| articles | pmc | 2.337517 | 12 |
| Axial | T2 | 2.337517 | 12 |
| T2 | weighted | 2.337517 | 12 |
| magnetic | weighted | 2.337517 | 12 |
| method | step | 2.324688 | 16 |
| ADT | cessation | 2.324688 | 16 |
| after | years | 2.305306 | 21 |
| dose | low | 2.259457 | 24 |
| low | rate | 2.196317 | 18 |
| magnetic | resonance | 2.190911 | 12 |
| images | resonance | 2.190911 | 12 |
| dose | effective | 2.154691 | 20 |
| https | www | 2.100804 | 20 |
| gov | ncbi | 2.082611 | 16 |
| Login | 管理用 | 2.07921 | 10 |
| biz | journal | 2.059489 | 8 |
| acm2 | full | 2.059489 | 8 |
| advanced | ductal | 2.044305 | 12 |
| external | radiotherapy | 2.036415 | 18 |
| 治療法の選択にあたり | 知っておきたいこと | 2.016923 | 8 |
| 再発のない治療を目指して | 知っておきたいこと | 2.016923 | 8 |
| vrVvR7mg0XU | watch | 2.016923 | 8 |
| Institute | Osaka | 2.016923 | 8 |
| 494ng | 最近の治療例を挙げれば治療前PSA | 2.016923 | 8 |
| 1ng | グリソンスコア4 | 2.016923 | 8 |
| 1ng | ml以下になっています | 2.016923 | 8 |
| ml以下になっています | テストステロンは正常値 | 2.016923 | 8 |
| 監視療法を採択し | 経過中 | 2.016923 | 8 |
| long | reports | 2.016923 | 8 |
| long | term | 2.016923 | 8 |
| aapm | onlinelibrary | 2.016923 | 8 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録